Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001239916-06-000005
Filing Date
2006-08-10
Accepted
2006-08-10 19:19:03
Documents
1
Period of Report
2006-08-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 2824
  Complete submission text file 0001239916-06-000005.txt   4544
Mailing Address 1600 FARADAY AVE CARLSBAD CA 92008
Business Address 1600 FARADAY AVE CARLSBAD CA 92008 7606037200
INVITROGEN CORP (Issuer) CIK: 0001073431 (see all company filings)

EIN.: 330373077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 12 PINE STREET PHILADELPHIA PA 19106
Business Address
UPRICHARD DAVID C (Reporting) CIK: 0001239916 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-25317 | Film No.: 061022698